Retraction notice to "Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial" [J Gynecol Obstet Hum Reprod 49 (2019) 101728]
- PMID: 41313845
- DOI: 10.1016/j.jogoh.2025.103077
Retraction notice to "Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial" [J Gynecol Obstet Hum Reprod 49 (2019) 101728]
Retraction of
-
Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial.J Gynecol Obstet Hum Reprod. 2020 May;49(5):101728. doi: 10.1016/j.jogoh.2020.101728. Epub 2020 Mar 12. J Gynecol Obstet Hum Reprod. 2020. Retraction in: J Gynecol Obstet Hum Reprod. 2026 Jan;55(1):103077. doi: 10.1016/j.jogoh.2025.103077. PMID: 32173633 Retracted. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
